Literature DB >> 32142659

Tackling the Many Facets of Glioblastoma Heterogeneity.

Itay Tirosh1, Mario L Suvà2.   

Abstract

Glioblastoma is an incurable brain tumor notorious for its heterogeneity. Recent studies in Cell (Jacob et al., 2020) and Cell Stem Cell (Bhaduri et al., 2020) leverage novel glioblastoma organoid models and single-cell RNA-sequencing technologies to tackle glioblastoma's heterogeneous nature, providing new tools and insights into tumor biology.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID： 32142659     DOI： 10.1016/j.stem.2020.02.005

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  13 in total

1.  NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBM.

Authors:  Youngjoon Park; Minwoo Park; Junhyung Kim; Juwon Ahn; Jeongmin Sim; Ji-In Bang; Jinhyung Heo; Hyejeong Choi; Kyunggi Cho; Mihye Lee; Jong-Seok Moon; Jaejoon Lim
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

Review 2.  Necrotic reshaping of the glioma microenvironment drives disease progression.

Authors:  Steven M Markwell; James L Ross; Cheryl L Olson; Daniel J Brat
Journal:  Acta Neuropathol       Date:  2022-01-17       Impact factor: 15.887

3.  Targeting radiation-tolerant persister cells as a strategy for inhibiting radioresistance and recurrence in glioblastoma.

Authors:  Jintao Gu; Nan Mu; Bo Jia; Qingdong Guo; Luxiang Pan; Maorong Zhu; Wangqian Zhang; Kuo Zhang; Weina Li; Meng Li; Lichun Wei; Xiaochang Xue; Yingqi Zhang; Wei Zhang
Journal:  Neuro Oncol       Date:  2022-07-01       Impact factor: 13.029

4.  Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells.

Authors:  Jiao Wang; Sandra Toregrosa-Allen; Bennett D Elzey; Sagar Utturkar; Nadia Atallah Lanman; Victor Bernal-Crespo; Matthew M Behymer; Gregory T Knipp; Yeonhee Yun; Michael C Veronesi; Anthony L Sinn; Karen E Pollok; Randy R Brutkiewicz; Kathryn S Nevel; Sandro Matosevic
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-09       Impact factor: 12.779

Review 5.  A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma.

Authors:  Sascha Marx; Anze Godicelj; Kai W Wucherpfennig
Journal:  Semin Immunopathol       Date:  2022-05-03       Impact factor: 11.759

Review 6.  Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?

Authors:  William Echavidre; Vincent Picco; Marc Faraggi; Christopher Montemagno
Journal:  Pharmaceutics       Date:  2022-05-13       Impact factor: 6.525

Review 7.  The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions.

Authors:  Kelly Mitchell; Katie Troike; Daniel J Silver; Justin D Lathia
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

8.  Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres.

Authors:  Seon-Jin Yoon; Hye Young Son; Jin-Kyoung Shim; Ju Hyung Moon; Eui-Hyun Kim; Jong Hee Chang; Wan Yee Teo; Se Hoon Kim; Sahng Wook Park; Yong-Min Huh; Seok-Gu Kang
Journal:  J Transl Med       Date:  2020-12-14       Impact factor: 5.531

Review 9.  Opportunities and challenges of glioma organoids.

Authors:  Xiangdong Xu; Lingfei Li; Linting Luo; Lingling Shu; Xiaoli Si; Zhenzhen Chen; Wenqing Xia; Jinyu Huang; Yang Liu; Anwen Shao; Yiquan Ke
Journal:  Cell Commun Signal       Date:  2021-10-11       Impact factor: 5.712

10.  Identification of PIEZO1 as a potential prognostic marker in gliomas.

Authors:  Wenjianlong Zhou; Xiangxiang Liu; Jan Willem Maurits van Wijnbergen; Linhao Yuan; Yuan Liu; Chuanbao Zhang; Wang Jia
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.